Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparison of NAFLD, MAFLD and MASLD characteristics and mortality outcomes in United States adults
Rui Song, Li Zhao, Yingzhi Zhang, et al.
Liver International (2024) Vol. 44, Iss. 4, pp. 1051-1060
Closed Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Current status and future trends of the global burden of MASLD
Lei Miao, Giovanni Targher, Christopher D. Byrne, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 8, pp. 697-707
Closed Access | Times Cited: 214
Metabolic Dysfunction and Alcohol-related Liver Disease (MetALD): Position statement by an expert panel on alcohol-related liver disease
Juan Pablo Arab, Luis Antonio Díaz, Jürgen Rehm, et al.
Journal of Hepatology (2024)
Closed Access | Times Cited: 26
MASLD/MetALD and mortality in individuals with any cardio-metabolic risk factor: A population-based study with 26.7 years of follow-up
Min‐Sun Kwak, Hyun-seok Kim, Z. Gordon Jiang, et al.
Hepatology (2024)
Closed Access | Times Cited: 22
Heavy arch: from inflammatory bowel diseases to metabolic disorders
Timon E. Adolph, Moritz Meyer, A Jukic, et al.
Gut (2024) Vol. 73, Iss. 8, pp. 1376-1387
Open Access | Times Cited: 20
Liver and cardiovascular outcomes in lean non-alcoholic fatty liver disease: an updated systematic review and meta-analysis of about 1 million individuals
Matheus Souza, Ivanna Diaz, Lubna Al‐Sharif
Hepatology International (2024) Vol. 18, Iss. 5, pp. 1396-1415
Closed Access | Times Cited: 13
Relationship between Helicobacter pylori infection and risk of metabolic dysfunction‐associated steatotic liver disease: An updated meta‐analysis
Alessandro Mantovani, Maria Giovanna Lando, Nicolò Diego Borella, et al.
Liver International (2024) Vol. 44, Iss. 7, pp. 1513-1525
Open Access | Times Cited: 9
Weight-adjusted waist index is positively and linearly associated with all-cause and cardiovascular mortality in metabolic dysfunction-associated steatotic liver disease: findings from NHANES 1999-2018
Weijie Liu, Xiulin Yang, Ting Zhan, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 7
Kidney function mediates the association of per- and poly-fluoroalkyl substances (PFAS) and heavy metals with hepatic fibrosis risk
Zhengqi Wei, Jincheng Liu, Na Wang, et al.
Environmental Research (2024), pp. 120092-120092
Closed Access | Times Cited: 6
Use of non‐invasive diagnostic tools for metabolic dysfunction‐associated steatohepatitis: A qualitative exploration of challenges and barriers
Emmanuel Tsochatzis, Luca Valenti, Maja Thiele, et al.
Liver International (2024) Vol. 44, Iss. 8, pp. 1990-2001
Closed Access | Times Cited: 6
Leisure-Time Physical Activity in Subjects with Metabolic-Dysfunction-Associated Steatotic Liver Disease: An All-Cause Mortality Study
Ritanna Curci, Caterina Bonfiglio, Isabella Franco, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 13, pp. 3772-3772
Open Access | Times Cited: 5
Gut Microbiota and Sinusoidal Vasoregulation in MASLD: A Portal Perspective
György Baffy, Piero Portincasa
Metabolites (2024) Vol. 14, Iss. 6, pp. 324-324
Open Access | Times Cited: 4
Metabolic (dysfunction)-associated fatty liver disease metrics and contributions to liver research
Maito Suoh, Saeed Esmaili, Mohammed Eslam, et al.
Hepatology International (2024)
Open Access | Times Cited: 4
Magnesium Depletion Score and Mortality in Individuals with Metabolic Dysfunction Associated Steatotic Liver Disease over a Median Follow-Up of 26 Years
Lei Fan, Xiangzhu Zhu, Xinyuan Zhang, et al.
Nutrients (2025) Vol. 17, Iss. 2, pp. 244-244
Open Access
Clinical Relevancies of Sarcopenic Obesity in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease (MASLD)
Shih-Chieh Chien, Hung‐Chih Chiu, Yen‐Cheng Chiu, et al.
Digestive Diseases and Sciences (2025)
Closed Access
Prognostic and predictive effects of new steatotic liver disease nomenclatures: a large population‐based study
Huixian Zeng, Letian Fang, Zhiyu Yang, et al.
MedComm (2025) Vol. 6, Iss. 2
Open Access
A Comparison of Metabolic-Associated Fatty Liver Disease and Steatotic Liver Disease in a Cohort of Egyptian People Living with Human Immunodeficiency Virus
Fatma Elrashdy, Rahma Mohamed, Ahmed Cordie, et al.
Metabolic Syndrome and Related Disorders (2025)
Closed Access
Risk-stratified hepatocellular carcinoma surveillance in non-cirrhotic patients with MASLD
Ke Mi, Tingdan Ye, Lin Zhu, et al.
Gastroenterology report (2025) Vol. 13
Open Access
Clinical application of bile acid profile combined with lipid indices in metabolic dysfunction-associated steatotic liver disease
Zhenhua Liu, Hongwei Gao, Yan Wen, et al.
Clinica Chimica Acta (2025), pp. 120217-120217
Closed Access
From NAFLD to MASLD: transforming steatotic liver disease diagnosis and management
Paula Iruzubieta, Carolina Jiménez-González, Joaquín Cabezas, et al.
Metabolism and Target Organ Damage (2025) Vol. 5, Iss. 1
Open Access
Weight-adjusted waist circumference index with hepatic steatosis and fibrosis in adult females: a cross-sectional, nationally representative study (NHANES 2017–2020)
Yue Lian, Yixuan Wang, Yinyin Yang, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
Sleep Duration, Midpoint, Variability, Irregularity and Metabolic Dysfunction-Associated Steatotic Liver Disease
Qingcui Wu, Fuhai Song, Huijie Huang, et al.
Behavioral Sleep Medicine (2025), pp. 1-14
Closed Access
Association between metabolic dysfunction-associated steatotic liver disease, metabolic dysfunction subtypes and risk of colorectal cancer: A Prospective Cohort Study
Yuan Li, Xiangming Ma, Jianguo Jia, et al.
Clinics and Research in Hepatology and Gastroenterology (2025), pp. 102573-102573
Closed Access
Inflammatory and metabolic markers mediate the association of hepatic steatosis and fibrosis with 10-year ASCVD risk
Zihao Gui, Xingying Chen, Dongmei Wang, et al.
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access
Pomegranate‐Derived Exosome‐Like Nanovesicles Containing Ellagic Acid Alleviate Gut Leakage and Liver Injury in MASLD
Jisu Kim, Byoung‐Joon Song, Young‐Eun Cho
Food Science & Nutrition (2025) Vol. 13, Iss. 4
Open Access
MAFLD vs. MASLD: a year in review
Mingqian Jiang, Amna Subhan Butt, Ian Homer, et al.
Expert Review of Endocrinology & Metabolism (2025), pp. 1-12
Closed Access
Page 1 - Next Page

Scroll to top